PHILADELPHIA — As blockbuster weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro sweep across the globe, transforming from niche pharmaceutical treatments into cultural phenomena almost overnight, researchers are facing a monumental data gap. While traditional clinical trials remain the gold standard for establishing drug efficacy and identifying critical safety concerns, they often struggle to […]

